Related Experiment Video
Updated: May 6, 2026
Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
Heterogeneity and new epitopes of hepatitis C virus genotype 4
Moataza H Omran1, Wael Nabil, Samar S Youssef
1Microbial Biotechnology Department, Genetic Engineering Division, National Research Centre, Dokki Cairo, Egypt.
Insights
Hepatitis C virus (HCV) genetic diversity in Egypt was high, with 15% variation in genotype 4 strains. This research identified key viral regions and glycosylation sites crucial for developing effective HCV vaccines and therapies.
Area of Science:
- Virology
- Immunology
- Genetics
Background:
- Hepatitis C virus (HCV) significantly contributes to liver disease, evading host defenses.
- HCV's genetic heterogeneity is a major obstacle for vaccine and therapeutic development.
Purpose of the Study:
- To analyze the genetic diversity of Egyptian HCV genotype 4 isolates, focusing on the E1 and E2 regions.
- To understand the role of these regions in viral persistence and immune evasion.
Main Methods:
- Polymerase Chain Reaction (PCR) amplification of E1 and E2 regions.
- DNA sequencing and phylogenetic analysis.
- Identification of glycosylation sites and epitope domains.
Main Results:
- High genetic diversity (15%) was observed in local HCV genotype 4a strains.
- Four critical glycosylation sites involved in viral entry and protein folding were identified.
- Distinct epitope domains were mapped, aiding in the differentiation of neutralizing and non-neutralizing antibodies.
Conclusions:
- The findings enhance understanding of HCV genetic diversity drivers.
- Identified viral targets are fundamental for developing candidate antibodies and vaccine strategies.
Background:
Hepatitis C virus (HCV) was found to have a major role in human liver disease by its ability to face the host-cell defenses and the immune system. Heterogeneity of HCV was the key for its adaptation to its host and represented a significant hurdle for the development of both effective vaccines as well as for novel therapeutic interventions.
Objectives:
Due to the heterogeneity of HCV virus because of both high replication and high mutation rate in vivo, this study was conducted to analyze different isolates of Egyptian patients of genotype 4, of the most mutant regions of the virus (E1 and E2) as they played an important role in viral persistence by escaping from the immune system of the host body.
Patients And Methods:
This study was conducted through PCR amplification of E1 and E2 regions, sequencing and phylogenetic analysis, calculating synonyms and non-synonyms substitutions, finding the possible glycosylation sites and different epitope domains.
Results:
The present work figured out that the heterogeneity of the quasispecies of our local strains 4a was high showing up 15% diversity. This study also showed four glycosylation sites that play an important role in the entry of the virus and protein folding. Besides, different epitpoes were identified in different regions of the E1 and E2 domains; a finding which would help in determining the neutralizing and non- neutralizing antibodies.
Conclusions:
This study would help in understanding the driving forces of genetic diversity and would be fundamental for representing potential candidate targets for antibodies and the development of vaccine trials.
Related Concept Videos
01:25Hepatitis
01:28Viral Hepatitis I: Introduction